Licensing Considerations and eCOA Vendor Collaborations

Episode 9 January 30, 2024 00:26:26
Licensing Considerations and eCOA Vendor Collaborations
LifeSci Talks
Licensing Considerations and eCOA Vendor Collaborations

Jan 30 2024 | 00:26:26

/

Show Notes

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation Team at AbbVie, to cover the intricacies of clinical trial licensing, contract variations among eCOA providers, the importance of sponsor involvement, and the challenges of validated translations. Explore the complexities that can arise in these critical aspects of clinical trials

Other Episodes

Episode 17

November 25, 2024 00:23:33
Episode Cover

Measuring What Matters: Modernizing Clinical Outcome Assessments with Patient-Centric Approaches

In this episode of LifeSci Talks, TransPerfect’s Global Practice Leader Mark Wade sits down with Dr. Karl McEvoy, VP of eCOA and Patient Technology...

Listen

Episode 10

February 27, 2024 00:19:41
Episode Cover

PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials

In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd...

Listen

Episode 22

September 11, 2025 00:19:48
Episode Cover

Silver Bullet or Useful Repositories: The Reality of Clinical Trial Libraries

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, is joined by Jonathan Norman, Director of Translation and...

Listen